← FDA Drug Approvals (Drugs@FDA)
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2015-04-01
Drug application
- FDA Application #
ANDA202086
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
- Generic name
- NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- XIROMED
- Manufacturer
- Mylan Pharmaceuticals Inc.
- First approval
- 2015-04-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown